Markets & Investing

Alibaba-backed e-parenting firm eyes $1b Hong Kong IPO

Babytree is targeting a valuation of up to US$5b.

Goldman-backed heart valve startup eyes Hong Kong IPO

Venus MedTech is said to be aiming to raise up to US$500m.

Hong Kong's first pre-profit biotech float Ascletis closes flat on debut

It sold 224 million shares with an IPO priced at the middle end.

China Tower raises US$6.9b in another lacklustre debut

It sold 43.1 billion shares after pricing its IPO at the low end.

Cancer drug developer seeks $7b in secondary Hong Kong listing

BeiGene is offering 65.6 million shares at $94.9 to $111.6 apiece.

Hong Kong Exchange delays WVR plans

The bourse isn't pushing through with a planned stakeholder consultation.

Shanghai-based heart implant maker mulls Hong Kong IPO

Microport Scientific Corp could raise about US$200m in a share sale.

Has China Tower lured Alibaba and Hillhouse Capital to its mega IPO?

Reports claim they are investing around US$500m in the firm.

HKEX and Chinese stock exchanges reach agreement to include WVR companies

A joint working group will be established to achieve this goal.

China Tower eyes US$8.8b in IPO that would put Xiaomi to shame

Xiaomi only raised US$5.4b in its earlier listing.

Hong Kong dollar plunges to record low at $7.85

This marks the first breach since the range was imposed in 2005.

Hong Kong's richest woman loses US$6b as casino firm crashes

The losses began after authorities warned that the shares were concentrated amongst a small stockholder group.

HKEX ties up with MSCI to launch new Asian futures offerings

The move aims to boost its derivative business which accounts for 18% of HKEX revenue in 2017.

Tech giants challenge HKEX reform provisions

The listing proposal is seen clashing with draft rules in the Mainland.